GT Biopharma Inc (GTBP)
3.10
+0.15
(+5.08%)
USD |
NASDAQ |
Jun 26, 13:19
GT Biopharma Accounts Receivable (Quarterly)
Accounts Receivable (Quarterly) Chart
Historical Accounts Receivable (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.005M |
| March 31, 2014 | 0.03M |
| December 31, 2013 | 0.04M |
| September 30, 2013 | |
| June 30, 2013 | |
| March 31, 2013 | |
| December 31, 2012 | 0.00 |
| September 30, 2012 | |
| June 30, 2012 | |
| March 31, 2012 | |
| December 31, 2011 | |
| September 30, 2011 | |
| June 30, 2011 | |
| March 31, 2011 | |
| December 31, 2010 | |
| September 30, 2010 | |
| June 30, 2010 | |
| March 31, 2010 | 0.00 |
| December 31, 2009 | |
| September 30, 2009 | 0.014M |
| June 30, 2009 | 0.01M |
| March 31, 2009 | 0.004M |
| December 31, 2008 | |
| September 30, 2008 | 0.226M |
| Date | Value |
|---|---|
| June 30, 2008 | 0.267M |
| March 31, 2008 | 0.885M |
| December 31, 2007 | 0.83M |
| September 30, 2007 | 0.832M |
| June 30, 2007 | 1.126M |
| March 31, 2007 | 0.82M |
| December 31, 2006 | 0.732M |
| September 30, 2006 | 0.894M |
| June 30, 2006 | 0.93M |
| March 31, 2006 | 1.002M |
| December 31, 2005 | 0.865M |
| September 30, 2005 | 0.297M |
| June 30, 2005 | 0.272M |
| March 31, 2005 | 0.342M |
| December 31, 2004 | 0.229M |
| September 30, 2004 | 0.37M |
| June 30, 2004 | 0.198M |
| March 31, 2004 | 0.291M |
| December 31, 2003 | 0.251M |
| September 30, 2003 | 0.265M |
| June 30, 2003 | 0.22M |
| March 31, 2003 | 0.254M |
| December 31, 2002 | 0.188M |
| September 30, 2002 | 0.196M |
| June 30, 2002 | 0.136M |
Accounts Receivable Definition
Account used to record sales made "on account", meaning that the company has made a sale but has not collected payment. When company collects cash as payment, the corresponding account receivable is decreased.
Accounts Receivable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Receivable (Quarterly) Benchmarks
| Cutera Inc | 37.02M |
| Oragenics Inc | -- |
| Outlook Therapeutics Inc | -- |
| 180 Life Sciences Corp | -- |
| Scorpius Holdings Inc | 0.535M |